fda glp-1 news november 2025 Beyond the Headlines: Warning Letters to Compounders Compounded GLP-1s: Why doctors worry

In August 2025, Adia Med announced its entry into the USD 1.9 billion glutathione market through the launch of innovative IV glutathione therapies and Glutaryl Transdermal Glutathione Spray

In this review, we discuss the physiological significance of iron homeostasis in the body, the potential contribution of ferroptosis to the etiology and development of human diseases, along with the evidence supporting targeting ferroptosis as a therapeutic approach

Laboratory studies have suggested that GLP-1 receptor activation may modulate inflammatory pathways, though the clinical relevance of these findings remains uncertain

Standard titration logic assumes a monotonic dose-response that more produces more